The development of self-originated new drugs by Swiss pharmaceutical firms, 1960–1980
- 30 June 1984
- journal article
- clinical trial
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 4 (2) , 157-173
- https://doi.org/10.1016/0273-2300(84)90038-2
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- New drug development during and after a period of regulatory change: Clinical research activity of major united states pharmacxeutical firms, 1958 to 1979Clinical Pharmacology & Therapeutics, 1983
- New drug development by United States pharmaceutical firms: With analyses of trends in the acquisition and origin of drug candidates, 1963-1979*Clinical Pharmacology & Therapeutics, 1982